|
Market Closed -
Sao Paulo
01:01:55 15/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 136.22 BRL | +0.20% |
|
-0.25% | -19.23% |
| 10:59am | Hutchmed's Savolitinib Combo Improves Survival in Lung Cancer Trial; Shares Jump 5% | MT |
| 14/08 | FTSE 100 drifts lower in mixed day for Europe | AN |
| Market Cap | 24TCr 1,26000Cr 21TCr 20TCr 18TCr 33TCr 23,02700Cr 34TCr 2,29000Cr 90TCr 11,53100Cr 90TCr 88TCr 38,32000Cr | P/E 2026 * |
19.9x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 26TCr 1,36100Cr 22TCr 21TCr 19TCr 36TCr 24,87500Cr 37TCr 2,47400Cr 97TCr 12,45700Cr 98TCr 96TCr 41,39500Cr | EV / Sales 2026 * |
4.11x | EV / Sales 2027 * | 3.78x |
| Free-Float |
96.63% | Yield 2026 * |
2.14% | Yield 2027 * | 2.27% |
Last Transcript: AstraZeneca PLC
| 1 day | +0.20% | ||
| 1 week | -0.25% | ||
| Current month | -5.26% | ||
| 1 month | -4.93% | ||
| 3 months | -10.97% | ||
| 6 months | -24.12% | ||
| Current year | -19.23% |
| 1 week | 133.75 |  | 137.78 |
| 1 month | 130.06 | | 149.01 |
| Current year | 130.06 | | 190.4 |
| 1 year | 130.02 | | 190.4 |
| 3 years | 101.6 | | 190.4 |
| 5 years | 93.74 | | 190.4 |
| 10 years | 93.74 | | 190.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.20% | -0.25% | - | - | 24TCr | |
| -2.25% | -0.47% | +68.30% | +116.05% | 1,05200Cr | |
| -0.66% | +0.43% | +47.39% | +51.02% | 63TCr | |
| -0.54% | +1.39% | +20.69% | +64.61% | 44TCr | |
| -1.99% | -3.32% | +38.71% | +36.26% | 35TCr | |
| -1.05% | -2.81% | +23.07% | +35.91% | 29TCr | |
| -2.12% | -3.67% | -1.14% | +5.35% | 24TCr | |
| -0.63% | +1.04% | +40.05% | +56.67% | 22TCr | |
| -1.19% | -3.41% | -9.57% | -53.50% | 20TCr | |
| +0.16% | +3.87% | +16.89% | +77.38% | 17TCr | |
| Average | -1.01% | -0.77% | +27.15% | +43.31% | 39.95TCr | |
| Weighted average by Cap. | -1.26% | -0.63% | +39.09% | +61.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.33TCr 33TCr 5.46TCr 5.13TCr 4.67TCr 8.78TCr 6,04800Cr 8.92TCr 60TCr 24TCr 3,02900Cr 24TCr 23TCr 10,06500Cr | 6.69TCr 35TCr 5.77TCr 5.43TCr 4.93TCr 9.28TCr 6,39300Cr 9.43TCr 64TCr 25TCr 3,20100Cr 25TCr 25TCr 10,63800Cr |
| Net income | 1.21TCr 6.32TCr 1.04TCr 979.62Cr 890.92Cr 1.67TCr 1,15400Cr 1.7TCr 11TCr 4.49TCr 58TCr 4.53TCr 4.43TCr 1,92100Cr | 1.37TCr 7.18TCr 1.18TCr 1.11TCr 1.01TCr 1.9TCr 1,31200Cr 1.93TCr 13TCr 5.1TCr 66TCr 5.15TCr 5.04TCr 2,18300Cr |
| Net Debt | 1.93TCr 10TCr 1.67TCr 1.57TCr 1.43TCr 2.68TCr 1,84800Cr 2.73TCr 18TCr 7.19TCr 93TCr 7.26TCr 7.1TCr 3,07500Cr | 1.17TCr 6.1TCr 1.01TCr 946.22Cr 860.54Cr 1.62TCr 1,11500Cr 1.64TCr 11TCr 4.33TCr 56TCr 4.38TCr 4.28TCr 1,85500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | R$136.22 | +0.17% | 864 |
| 13/26/13 | R$135.99 | +0.03% | 104 |
| 12/26/12 | R$135.95 | -0.23% | 1,065 |
| 11/26/11 | R$136.26 | -1.00% | 65 |
| 10/26/10 | R$137.63 | +0.78% | 48 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- A1ZN34 Stock
Select your edition
All financial news and data tailored to specific country editions
